These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 21035554)

  • 1. Volumetric MRI and MRS provide sensitive measures of Alzheimer's disease neuropathology in inducible Tau transgenic mice (rTg4510).
    Yang D; Xie Z; Stephenson D; Morton D; Hicks CD; Brown TM; Sriram R; O'Neill S; Raunig D; Bocan T
    Neuroimage; 2011 Feb; 54(4):2652-8. PubMed ID: 21035554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sex difference in pathology and memory decline in rTg4510 mouse model of tauopathy.
    Yue M; Hanna A; Wilson J; Roder H; Janus C
    Neurobiol Aging; 2011 Apr; 32(4):590-603. PubMed ID: 19427061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Age related changes in brain metabolites observed by 1H MRS in APP/PS1 mice.
    Oberg J; Spenger C; Wang FH; Andersson A; Westman E; Skoglund P; Sunnemark D; Norinder U; Klason T; Wahlund LO; Lindberg M
    Neurobiol Aging; 2008 Sep; 29(9):1423-33. PubMed ID: 17434239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systematic evaluation of magnetic resonance imaging and spectroscopy techniques for imaging a transgenic model of Alzheimer's disease (AβPP/PS1).
    Esteras N; Alquézar C; Bartolomé F; Antequera D; Barrios L; Carro E; Cerdán S; Martín-Requero A
    J Alzheimers Dis; 2012; 30(2):337-53. PubMed ID: 22406445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Magnetic resonance spectroscopic analysis of Alzheimer's disease mouse brain that express mutant human APP shows altered neurochemical profile.
    Dedeoglu A; Choi JK; Cormier K; Kowall NW; Jenkins BG
    Brain Res; 2004 Jun; 1012(1-2):60-5. PubMed ID: 15158161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Puromycin-sensitive aminopeptidase (PSA/NPEPPS) impedes development of neuropathology in hPSA/TAU(P301L) double-transgenic mice.
    Kudo LC; Parfenova L; Ren G; Vi N; Hui M; Ma Z; Lau K; Gray M; Bardag-Gorce F; Wiedau-Pazos M; Hui KS; Karsten SL
    Hum Mol Genet; 2011 May; 20(9):1820-33. PubMed ID: 21320871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Longitudinal neuroanatomical changes determined by deformation-based morphometry in a mouse model of Alzheimer's disease.
    Lau JC; Lerch JP; Sled JG; Henkelman RM; Evans AC; Bedell BJ
    Neuroimage; 2008 Aug; 42(1):19-27. PubMed ID: 18547819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel transgenic mouse expressing double mutant tau driven by its natural promoter exhibits tauopathy characteristics.
    Rosenmann H; Grigoriadis N; Eldar-Levy H; Avital A; Rozenstein L; Touloumi O; Behar L; Ben-Hur T; Avraham Y; Berry E; Segal M; Ginzburg I; Abramsky O
    Exp Neurol; 2008 Jul; 212(1):71-84. PubMed ID: 18490011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predisposition to accelerated Alzheimer-related changes in the brains of human immunodeficiency virus negative opiate abusers.
    Anthony IC; Norrby KE; Dingwall T; Carnie FW; Millar T; Arango JC; Robertson R; Bell JE
    Brain; 2010 Dec; 133(Pt 12):3685-98. PubMed ID: 21126996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered neurochemical profile in the McGill-R-Thy1-APP rat model of Alzheimer's disease: a longitudinal in vivo 1 H MRS study.
    Nilsen LH; Melø TM; Saether O; Witter MP; Sonnewald U
    J Neurochem; 2012 Nov; 123(4):532-41. PubMed ID: 22943908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Magnetic resonance imaging of Alzheimer's pathology in the brains of living transgenic mice: a new tool in Alzheimer's disease research.
    Jack CR; Marjanska M; Wengenack TM; Reyes DA; Curran GL; Lin J; Preboske GM; Poduslo JF; Garwood M
    Neuroscientist; 2007 Feb; 13(1):38-48. PubMed ID: 17229974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterizing the regional structural difference of the brain between tau transgenic (rTg4510) and wild-type mice using MRI.
    Xie Z; Yang D; Stephenson D; Morton D; Hicks C; Brown T; Bocan T
    Med Image Comput Comput Assist Interv; 2010; 13(Pt 1):308-15. PubMed ID: 20879245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo axonal transport deficits in a mouse model of fronto-temporal dementia.
    Majid T; Ali YO; Venkitaramani DV; Jang MK; Lu HC; Pautler RG
    Neuroimage Clin; 2014; 4():711-7. PubMed ID: 24936422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Striatum and entorhinal cortex atrophy in AD mouse models: MRI comprehensive analysis.
    Micotti E; Paladini A; Balducci C; Tolomeo D; Frasca A; Marizzoni M; Filibian M; Caroli A; Valbusa G; Dix S; O'Neill M; Ozmen L; Czech C; Richardson JC; Frisoni GB; Forloni G
    Neurobiol Aging; 2015 Feb; 36(2):776-88. PubMed ID: 25433456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alzheimer's disease-like tau neuropathology leads to memory deficits and loss of functional synapses in a novel mutated tau transgenic mouse without any motor deficits.
    Schindowski K; Bretteville A; Leroy K; Bégard S; Brion JP; Hamdane M; Buée L
    Am J Pathol; 2006 Aug; 169(2):599-616. PubMed ID: 16877359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The comparative study on high field MRI and pathology of Alzheimer's disease transgenic mice].
    Li MH; Wang PJ; Chen SQ; Zhang W; Gao XL
    Zhonghua Yi Xue Za Zhi; 2011 Apr; 91(13):876-9. PubMed ID: 21600112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High dietary consumption of trans fatty acids decreases brain docosahexaenoic acid but does not alter amyloid-beta and tau pathologies in the 3xTg-AD model of Alzheimer's disease.
    Phivilay A; Julien C; Tremblay C; Berthiaume L; Julien P; Giguère Y; Calon F
    Neuroscience; 2009 Mar; 159(1):296-307. PubMed ID: 19135506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered function of hippocampal CA1 pyramidal neurons in the rTg4510 mouse model of tauopathy.
    Dalby NO; Volbracht C; Helboe L; Larsen PH; Jensen HS; Egebjerg J; Elvang AB
    J Alzheimers Dis; 2014; 40(2):429-42. PubMed ID: 24448785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MRI and CSF studies in the early diagnosis of Alzheimer's disease.
    de Leon MJ; DeSanti S; Zinkowski R; Mehta PD; Pratico D; Segal S; Clark C; Kerkman D; DeBernardis J; Li J; Lair L; Reisberg B; Tsui W; Rusinek H
    J Intern Med; 2004 Sep; 256(3):205-23. PubMed ID: 15324364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histochemical visualization and diffusion MRI at 7 Tesla in the TgCRND8 transgenic model of Alzheimer's disease.
    Thiessen JD; Glazner KA; Nafez S; Schellenberg AE; Buist R; Martin M; Albensi BC
    Brain Struct Funct; 2010 Jul; 215(1):29-36. PubMed ID: 20512361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.